Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AbbVie
Hospitals
Bristol Myers Squibb latest to roll out 340B restrictions
Bristol Myers Squibb became the 12th drugmaker, and second in the past month, to announce a policy for 340B contract pharmacy restrictions.
Robert King
Jan 19, 2022 9:30am
AbbVie latest to impose 340B sales restrictions
Jan 5, 2022 9:30am
House Dems: 14 drugmakers spent $577B on buybacks, dividends
Jul 9, 2021 7:05am
Healthcare stocks rise following midterm election—roundup
Nov 9, 2018 12:05am
Questions about disclosures, studies bring down 2 researchers
Sep 20, 2018 1:05pm
Cigna expands its collaboration with Omada Health—roundup
Sep 19, 2018 8:39am
